Evidence map›Paper›PMID 40502859›Full record

ArticleThe Lancet regional health. Southeast Asia2025

The role of serum ferritin in predicting plasma leakage among adults and children with dengue in Sri Lanka: a multicentre, prospective cohort study.

Chamila Mettananda, Kesara Perera, Natheeha Nayeem, Matheesha Nayanajith, Ayesha Thewage, Ranjan Premaratna, Anuradha Dassanayake, Arunasalam Pathmeswaran, Sachith Mettananda

Abstract read
In one paragraph

Article in The Lancet regional health. Southeast Asia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chamila MettanandaDepartment of Pharmacology, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Kesara PereraDepartment of Pharmacology, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Natheeha NayeemDepartment of Pharmacology, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Matheesha NayanajithDepartment of Pharmacology, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Ayesha ThewageDepartment of Paediatrics, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Ranjan PremaratnaDepartment of Medicine, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Anuradha DassanayakeDepartment of Pharmacology, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Arunasalam PathmeswaranDepartment of Public Health, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Sachith MettanandaDepartment of Paediatrics, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Early prediction of plasma leakage helps in timely management of dengue. Currently, there are no defined early predictors of plasma leakage, and identified parameters are late predictors. Raised ferritin is associated with severe dengue, but its clinical utility early in the disease to predict severe dengue is not previously reported. We studied the efficacy of day 3 or 4 serum ferritin in predicting plasma leakage among adults and children with dengue in Sri Lanka. Methods: We conducted a prospective cohort study in four hospitals in Sri Lanka from June 2022 to June 2023. Consecutive and consenting patients admitted with dengue fever were included in the study. Patients with comorbidities where ferritin could be abnormal were excluded. Serum ferritin levels were prospectively measured daily until day 8 of the illness. Physician-diagnosed plasma leakage, defined as rising haematocrit ≥ 20% from baseline or ultrasound evidence of pleural effusion or ascites, was the main outcome. Data were collected using a proforma by perusing medical records. Prediction of plasma leakage by day 3 or 4 ferritin was studied using receiver operating characteristic curves (ROC). Findings: We studied 209 patients with dengue, of which 118 (56.5%) were males and median age was 20 years (IQR 9.0-40.5). Out of 209 patients, 70 (33.5%) developed plasma leakage. Median [IQR] ferritin levels on day 3 (926 [400-2752]) and day 4 (1249 [588-3005]) in patients who developed plasma leakage were higher than ferritin levels in patients who did not develop plasma leakage (p < 0.001) (day 3: 273 [101-620]) and (day 4: 506 [220-1226]). Performance of day 3 or 4 ferritin in predicting plasma leakage showed an area under the ROC of 0.78 (95% CI 0.70-0.85). The highest serum ferritin of day 3 or 4 had a positive predictive value of 52% and a negative predictive value of 84%. Interpretation: Day 3 or 4 ferritin levels correctly predicted plasma leakage status in 78% of the study samples. Serum ferritin levels measured on day 3 or 4 can be used as an early predictor of plasma leakage in dengue. Funding: University of Kelaniya Internal Research Grants 2022 (Grant reference number: RP/03/04/13/01/2022).

Indexed as

DengueEarly predictorPlasma leakageSerum ferritinSevere dengue

Identifiers

PMID40502859
PMCPMC12155916

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.